Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis, Scleroderma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06732674
What this trial is testing

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

Who this might be right for
Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified ElsewhereSystemic Sclerosis PulmonaryDermatomyositis+3 more
Oslo University Hospital 218
Testing effectiveness (Phase 2)Study completedNCT04647890
What this trial is testing

Effects of FT011 in Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicScleroderma, DiffuseSclerosis, Systemic
Certa Therapeutics 30
Large-scale testing (Phase 3)Ended earlyNCT01424033
What this trial is testing

A Clinical Trial for CTD-ILD Treatment

Who this might be right for
Interstitial Lung DiseaseConnective Tissue Disease
University of Michigan 5
Not applicableStudy completedNCT03965780
What this trial is testing

The SPIN - Scleroderma Support Group Leader EDucation Program Trial (SPIN-SSLED)

Who this might be right for
Scleroderma, Systemic
Lady Davis Institute 148
Large-scale testing (Phase 3)Study completedNCT00319033
What this trial is testing

Open-label Study With Bosentan in Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseScleroderma
Actelion 132
Large-scale testing (Phase 3)Study completedNCT00498615
What this trial is testing

A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon

Who this might be right for
RaynaudScleroderma
Johns Hopkins University 17
Large-scale testing (Phase 3)UnknownNCT05236491
What this trial is testing

COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisAutoimmune Rheumatologic DiseaseSystemic Lupus Erythematosus+6 more
Paul R Fortin 287
Post-approval studies (Phase 4)UnknownNCT04928586
What this trial is testing

Immunosuppressant Combined With Pirfenidone in CTD-ILD

Who this might be right for
PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
Qilu Hospital of Shandong University 200
Not applicableEnded earlyNCT02371005
What this trial is testing

Oral Manifestations of Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
University Hospital, Strasbourg, France 85
Not applicableStudy completedNCT04684225
What this trial is testing

Telerehabilitation on Hand-Affected Scleroderma

Who this might be right for
SclerodermaScleroderma, SystemicScleroderma Associated Digital Ulcer+3 more
Istanbul University 42
Testing effectiveness (Phase 2)Study completedNCT04387825
What this trial is testing

Safety Of Fat Micrografts With Adipose-Derived Stromal Vascular Fraction In Hands Of Patients With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 20
Not applicableStudy completedNCT05505617
What this trial is testing

Nitric Oxide Lung Diffusing Capacity in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Holger Dressel 9
Large-scale testing (Phase 3)UnknownNCT00428883
What this trial is testing

High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis

Who this might be right for
Scleroderma, Diffuse
Università Politecnica delle Marche 45
Testing effectiveness (Phase 2)Study completedNCT01241383
What this trial is testing

Effect of Bosentan in Scleroderma Renal Crisis

Who this might be right for
Scleroderma Renal Crisis
Assistance Publique - Hôpitaux de Paris 16
Not applicableUnknownNCT03444805
What this trial is testing

EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2)

Who this might be right for
Autoimmune Diseases
European Society for Blood and Marrow Transplantation 60
Large-scale testing (Phase 3)Looking for participantsNCT06297096
What this trial is testing

Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland 86
Early research (Phase 1)Ended earlyNCT02981082
What this trial is testing

Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

Who this might be right for
Systemic SclerosisPulmonary; Hypertension
Robert Lafyatis 6
Not applicableLooking for participantsNCT06182293
What this trial is testing

Periodontal Microbiota in Systemic Sclerosis

Who this might be right for
Scleroderma Systemic
University Hospital, Strasbourg, France 30
Not applicableStudy completedNCT03941184
What this trial is testing

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

Who this might be right for
SCADAddison DiseaseAnkylosing Spondylitis+26 more
Mayo Clinic 114
Testing effectiveness (Phase 2)Study completedNCT03007004
What this trial is testing

Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis Patients With Digital Ulcers
Gunma University 10
Next Page